Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nan Song

Showing results (601-610 of 612) with videos related to

Pageof 62
Sort By:
Cell Discovery|November 25, 2025
Surgery after induced anti-PD-L1 therapy and chemotherapy for stage I‒III small-cell lung cancer: a phase 2 trial (LungMate-005)Fenghuan Sun, Lele Zhang, Liangdong Sun, et al.
Journal of the National Cancer Institute|March 20, 2019
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast CancerRim S Kim, Nan Song, Patrick G Gavin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 2021
Polygenic Risk Score Improves Risk Stratification and Prediction of Subsequent Thyroid Cancer after Childhood CancerNan Song, Qi Liu, Carmen L Wilson, et al.
Experimental & Molecular Medicine|February 12, 2025
A1AT dysregulation of metabolically stressed hepatocytes by Kupffer cells drives MASH and fibrosisJeong-Su Park, Jin Lee, Feng Wang, et al.
Signal Transduction and Targeted Therapy|June 13, 2024
Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II-III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory studyHaoran Xia, Han Zhang, Zheng Ruan, et al.
Journal of Thoracic Disease|August 30, 2019
A new technology for reducing anastomotic fistula in the neck after esophageal cancer surgeryYa-Nan Song, Yu Qi, Chun-Yang Zhang, et al.
Cell|February 26, 2019
Acetylation Blocks cGAS Activity and Inhibits Self-DNA-Induced AutoimmunityJiang Dai, Yi-Jiao Huang, Xinhua He, et al.
Breast Cancer Research : BCR|December 5, 2019
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2<sup>+</sup> breast cancerSamuel A Jacobs, André Robidoux, Jame Abraham, et al.
Breast Cancer Research : BCR|January 24, 2020
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancerSamuel A Jacobs, André Robidoux, Jame Abraham, et al.
Expert Review of Medical Devices|October 6, 2022
Comparison of the supraglottic airway device BlockBusterTM and laryngeal mask airway Supreme in anaesthetised, paralyzed adult patients: a multicenter randomized controlled trialXue Gao, Ju-Hui Liu, Chun-Mei Chen, et al.
Pageof 62

Showing results (601-610 of 612) with videos related to

Sort By:
Pageof 62
Cell Discovery|November 25, 2025
Surgery after induced anti-PD-L1 therapy and chemotherapy for stage I‒III small-cell lung cancer: a phase 2 trial (LungMate-005)Fenghuan Sun, Lele Zhang, Liangdong Sun, et al.
Journal of the National Cancer Institute|March 20, 2019
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast CancerRim S Kim, Nan Song, Patrick G Gavin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 2021
Polygenic Risk Score Improves Risk Stratification and Prediction of Subsequent Thyroid Cancer after Childhood CancerNan Song, Qi Liu, Carmen L Wilson, et al.
Experimental & Molecular Medicine|February 12, 2025
A1AT dysregulation of metabolically stressed hepatocytes by Kupffer cells drives MASH and fibrosisJeong-Su Park, Jin Lee, Feng Wang, et al.
Signal Transduction and Targeted Therapy|June 13, 2024
Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II-III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory studyHaoran Xia, Han Zhang, Zheng Ruan, et al.
Journal of Thoracic Disease|August 30, 2019
A new technology for reducing anastomotic fistula in the neck after esophageal cancer surgeryYa-Nan Song, Yu Qi, Chun-Yang Zhang, et al.
Cell|February 26, 2019
Acetylation Blocks cGAS Activity and Inhibits Self-DNA-Induced AutoimmunityJiang Dai, Yi-Jiao Huang, Xinhua He, et al.
Breast Cancer Research : BCR|December 5, 2019
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2<sup>+</sup> breast cancerSamuel A Jacobs, André Robidoux, Jame Abraham, et al.
Breast Cancer Research : BCR|January 24, 2020
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancerSamuel A Jacobs, André Robidoux, Jame Abraham, et al.
Expert Review of Medical Devices|October 6, 2022
Comparison of the supraglottic airway device BlockBusterTM and laryngeal mask airway Supreme in anaesthetised, paralyzed adult patients: a multicenter randomized controlled trialXue Gao, Ju-Hui Liu, Chun-Mei Chen, et al.
Pageof 62